MedPath

CALIFORNIA PHARMACEUTICALS, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

FDA:12

Drug Approvals

Ranitidine Hydrochloride Oral Suspension Kit

Approval Date
Jan 5, 2018
FDA

Metaxalone

Approval Date
Jan 2, 2018
FDA

Pantoprazole Sodium

Approval Date
Jan 2, 2018
FDA

OXAPROZIN

Approval Date
Nov 3, 2017
FDA

SYNAPRYN

Approval Date
Aug 7, 2017
FDA

PANTOPRAZOLE SODIUM

Approval Date
Aug 4, 2017
FDA

CYCLOPHENE

Approval Date
Jul 25, 2016
FDA

KETOPHENE

Approval Date
Jul 21, 2016
FDA

Dicopanol

Approval Date
Jan 7, 2016
FDA

Fanatrex

Approval Date
Jan 7, 2016
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.